Menu Search
Equities

Dingdang Health Technology Group Ltd

9886:HKG

Dingdang Health Technology Group Ltd

Actions
Consumer Staples Personal Care, Drug and Grocery Stores
  • Price (HKD)0.57
  • Today's Change0.000 / 0.00%
  • Shares traded1.72m
  • 1 Year change-72.99%
  • Beta--
Data delayed at least 15 minutes, as of Nov 15 2024 08:08 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in CNYIncome statement in CNYView more

Year on year Dingdang Health Technology Group Ltd grew revenues 12.19% from 4.33bn to 4.86bn while net income improved from a loss of 2.83bn to a smaller loss of 225.81m.
Gross margin32.38%
Net profit margin-4.17%
Operating margin-3.68%
Return on assets-6.53%
Return on equity-9.72%
Return on investment-9.42%
More ▼

Cash flow in CNYView more

In 2023, Dingdang Health Technology Group Ltd did not generate a significant amount of cash. However, Cash Flow from Investing totalled 104.32m, indicating this company earned more from the sale of existing assets than it spent on the purchase of new assets. In addition the company used 5.24m for operations while cash used for financing totalled 130.54m.
Cash flow per share-0.065
Price/Cash flow per share--
Book value per share1.56
Tangible book value per share1.26
More ▼

Balance sheet in CNYView more

Dingdang Health Technology Group Ltd appears to have little financial risk as the company holds a substantial amount of cash on its books. In fact, 1.55% of the market capitalization can be attributed to its 1.19bn and debt could be paid in full if management chose.
Current ratio2.54
Quick ratio1.86
Total debt/total equity0.0828
Total debt/total capital0.0766
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.